Explore private publisher requirements →Peptide topic directory / AOD-9604
Publisher-review information
AOD-9604 Affiliate Program: Publisher Review
Publisher information for AOD-9604. Review the exact product or preparation, service scope and permitted promotion before discussing a campaign. Advertiser identities and commercial terms remain private.
Identity and public scope
AOD-9604 has its own publisher-review entry. Interest in the name does not establish an approved weight-management indication or a currently permissible preparation. The proposed product and campaign need their own documentation.
What publishers should establish
- Exact substance and formulation identity
- Current eligibility for the proposed preparation and use
- Substantiation for any proposed weight-related description
What stays private
The advertiser brief must identify the actual product or service, eligible markets, permitted content and payable event. No private advertiser, payout, creative asset or tracking link is disclosed here.
A familiar substance name or a related approved product is not a substitute for the current brief.
Before creating content
Keep informational coverage separate from promotion. Verify exact names and preparation details, cite current primary sources for status statements, and do not infer an indication, route or outcome from a directory entry.
No dosing, stacking, administration or blend-formula instructions are provided. Research reporting and a private publisher inquiry do not establish treatment availability.
AOD-9604 publisher questions
What is this AOD-9604 affiliate program page?
It is publisher information about AOD-9604. It supports preparation-specific review before any campaign is promoted.
Does this AOD-9604 page confirm campaign eligibility?
No blanket eligibility is established by the page. The exact product, preparation, service and current advertiser permissions must be reviewed privately.
Which name or formulation should a publisher use?
AOD-9604 has its own publisher-review entry. Interest in the name does not establish an approved weight-management indication or a currently permissible preparation. The proposed product and campaign need their own documentation.
Where are advertiser details and campaign terms reviewed?
Advertiser identities, payouts, approved creative, traffic permissions and tracking links are handled through the private publisher process.
Where can publishers apply for permitted telehealth programs?
Use MarketHealth Telehealth Publishers to describe your audience and proposed channels. An inquiry does not authorize promotion or establish access to an investigational product.
Status reference reviewed October 15, 2026: Official source. The reference provides context; it does not establish a MarketHealth campaign.
Related publisher information
Review private publisher requirements
Use the publisher application to discuss programs that meet current requirements. A public topic listing does not authorize an investigational or otherwise impermissible campaign.
Review private publisher access